Trials / Completed
CompletedNCT05242497
Effectiveness and Safety of Pharmacopuncture Therapy for Patients with Lumbar Spinal Stenosis
Effectiveness and Safety of Pharmacopuncture Therapy for Patients with Lumbar Spinal Stenosis : Multicentered, Pragmatic Randomized Controlled, Parallel Grouped Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 98 (actual)
- Sponsor
- Jaseng Medical Foundation · Academic / Other
- Sex
- All
- Age
- 19 Years – 69 Years
- Healthy volunteers
- Not accepted
Summary
This is 1:1 pragmatic randomized controlled trials in a parallel-grouped, multi-centered design that investigated pharmacopuncture therapy for patients with lumbar spinal stenosis, compared to the conservative treatments including physiotherapy and pharmacological treatments.
Detailed description
This is 1:1 pragmatic randomized controlled trials in a parallel-grouped, multi-centered design that investigated pharmacopuncture therapy for patients with lumbar spinal stenosis, compared to the conservative treatments including physiotherapy and pharmacological treatments. The physician will decide specific location, type, and doses of pharmacopuncture therapy or conservative treatments according to each participants' disease conditions, respectively. The researcher will record concurrently.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | pharmacopuncture | This is a pragmatic randomized controlled trials, so the physicians will choose pharmacopuncture treatment, including the type and doses, according to each participant's conditions. The researcher will record the specific intervention precisely and concurrently. |
| PROCEDURE | conservative treatments (including physiotherapy) | This is a pragmatic randomized controlled trials, so the physicians will choose conservative treatment, including physiotherapy and pharmacological treatment, according to each participant's conditions. The researcher will record the specific intervention precisely and concurrently. |
Timeline
- Start date
- 2022-04-13
- Primary completion
- 2024-01-19
- Completion
- 2024-10-28
- First posted
- 2022-02-16
- Last updated
- 2025-01-09
Locations
7 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05242497. Inclusion in this directory is not an endorsement.